BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27993212)

  • 1. Criteria derived from serum markers can precisely evaluate axillary status in breast cancer patients.
    Wan H; Du Z; Long Q; Lü Q; Li H
    J Surg Res; 2017 Feb; 208():211-218. PubMed ID: 27993212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
    Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
    Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore.
    Tan LG; Tan YY; Heng D; Chan MY
    Singapore Med J; 2005 Dec; 46(12):693-7. PubMed ID: 16308642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
    Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
    Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
    Dihge L; Bendahl PO; Rydén L
    Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved false negative rate of axillary status using sentinel lymph node biopsy and ultrasound-suspicious lymph node sampling in patients with early breast cancer.
    Wang Y; Dong H; Wu H; Zhang L; Yuan K; Chen H; Jiao M; Fu R
    BMC Cancer; 2015 May; 15():382. PubMed ID: 25956308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of sentinel lymph node in patients with early stage breast cancer].
    Tang J; Yang MT; Fan W; Wang X; Zhang X; Liang XM; Wang X; Xie ZM
    Ai Zheng; 2005 Sep; 24(9):1111-4. PubMed ID: 16159435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
    Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
    Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011.
    Boland MR; Prichard RS; Daskalova I; Lowery AJ; Evoy D; Geraghty J; Rothwell J; Quinn CM; O'Doherty A; McDermott EW
    Eur J Surg Oncol; 2015 Apr; 41(4):559-65. PubMed ID: 25648466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?
    Ngui NK; French J; Kilby CJ; Pathmanathan N; Elder EE
    J Surg Oncol; 2016 Jun; 113(7):726-31. PubMed ID: 27041002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Growth and Angiogenic Factors and Lymph Node Status in Early-stage Breast Cancer - A Pilot Study.
    Karlikova M; Topolcan O; Narsanska A; Kucera R; Treskova I; Treska V
    Anticancer Res; 2016 Aug; 36(8):4209-14. PubMed ID: 27466533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel lymph node biopsy in breast cancer patients--results and experience after 500 sentinel lymph node biopsies].
    Reitsamer R; Menzel C; Peintinger F; Cimpoca W; Glück S; Sinzinger G; Rettenbacher L; Kässmann H; Hoffmann A; Prokop E; Strasser F; Kiesler J; Hutarew G; Dietze O
    Gynakol Geburtshilfliche Rundsch; 2003 Apr; 43(2):98-103. PubMed ID: 12649582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary tumour burden in women with a fine-needle aspiration/core biopsy-proven positive node on ultrasonography compared to women with a positive sentinel node.
    Lloyd P; Theophilidou E; Newcombe RG; Pugh L; Goyal A
    Br J Surg; 2017 Dec; 104(13):1811-1815. PubMed ID: 28991362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of sentinel node biopsy in breast cancer patients with a high prevalence of axillary metastases.
    Moghimi M; Ghoddosi I; Rahimabadi AE; Sheikhvatan M
    Scand J Surg; 2009; 98(1):30-3. PubMed ID: 19447739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.